United States of America Viscosupplementation Market is Segmented By Dosage (Single Injection, Three...
Market Size in USD Bn
CAGR8.3%
Study Period | 2025-2032 |
Base Year of Estimation | 2024 |
CAGR | 8.3% |
Market Concentration | Medium |
Major Players | Johnson & Johnson., F. Hoffmann-La Roche AG, Zimmer Biomet, Sanofi S.A., Anika Therapeutics Inc. and Among Others |
The United States of America Viscosupplementation Market is estimated to be valued at USD 1.67 Bn in 2025 and is expected to reach USD 2.92 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.3% from 2025 to 2032.
The viscosupplementation market in the United States is expected to witness positive growth over the forecast period, owing to the rising geriatric population, who are more prone to osteoarthritis.